跳至主要内容
临床试验/NCT01956162
NCT01956162已完成不适用

Evaluation of a New Customized Removable Device With Rocker Sole for Plantar Off-Loading "Orthèse Diabète" in the Healing of Foot Ulcers in Diabetic Patients

Proteor Group2 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2013年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
118
试验地点
2
主要终点
Evaluate the efficiency of "Orthèse Diabète" compared to "conventional" removable devices, in terms of the proportion of diabetic patients whose principal ulcer will heal completely.

研究概览

简要总结

Multi-center trial, randomized in 2 parallel groups, open label, with a blinded adjudication committee (PROBE methodology), comparing "Orthèse Diabète" with "conventional" removable devices in terms of healing of ulcers.

  • Primary objective: Evaluate the efficiency of "Orthèse Diabète" compared to "conventional" removable devices, in terms of the proportion of diabetic patients whose principal ulcer will heal completely at 3 months.

详细描述

  1. Secondary objectives

  2. Proportion of patients whose principal ulcer will heal completely at 1, 2 and 6 months

  3. Proportion of patients in whom all initial plantar ulcers will heal completely at 1, 2, 3 and 6 months

  4. Percentage of area decrease of the plantar ulcers at 1, 2, 3 and 6 months

  5. Time to healing of the principal ulcer

  6. Appearance of new ulcers

  7. Requirement for amputation

  8. Incidence of the infectious complications

  9. Adherence of wearing

  10. Patient's satisfaction with the prescribed device

  11. Population

  12. 13 centers/116 patients monitored for a period of 6 months maximum

  13. Experimental Group: "Orthèse Diabète" a plantar off-loading custom-made removable device

  14. Control group: "Conventional" removable off-loading systems among the devices available in France.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 1 or type 2 diabetic patients diagnosed according to the ADA experts consensus [ADA 1997]
  • Over 18 years of age
  • With a sensory neuropathy (abnormal 10 g monofilament test, i.e. not perceived at least 2 times in 1 of the 3 areas explored : pulp of the great toe, 1st and 5th metatarsal heads)
  • Without a severe arteriopathy defined by : ABI < 0,7 and/or TcPO2 < 30 mm Hg and/or big toe pressure < 30 mm Hg
  • with one or more plantar ulcerations with an area > 0,25 cm² or an amputation (toes or transmetatarsal) open or sutured
  • not requiring a contralateral off-loading device
  • Informed about the study and having given their informed and written consent to participate
  • registered with a social security scheme or with the CMU (beneficiary or entitled recipient)
  • having undergone a medical exam
  • not included in another protocol throughout the study

排除标准

  • Severe skin or osteoarticular infection requiring a parenteral antibiotic therapy or surgery
  • Large ulcer of the ipsilateral leg > 20 cm2 of area
  • Contralateral above heel amputation
  • Intercurrent disease prohibiting participation in the protocol
  • Weight over 130 Kg
  • Person under tutorship or under curatorship
  • Loss of functional and/or neuropsychological autonomy
  • Pregnant or likely to be pregnant woman

结局指标

主要结局

Evaluate the efficiency of "Orthèse Diabète" compared to "conventional" removable devices, in terms of the proportion of diabetic patients whose principal ulcer will heal completely.

时间窗: At 3 months

Evaluated by taking photographs, measuring the ulcer area (using Digital Photo Planimetry DPP and the software Tracer.exe). Full healing defined by the adjudication committee based on the analysis of the photographs.

次要结局

  • Proportion of patients whose principal plantar ulcer will be fully healed(At 1, 2 and 6 months)
  • Proportion of patients whose all initial plantar ulcers will be fully healed.(At 1, 2, 3 and 6 months)
  • Percentage decrease of the ulcer area(At 1, 2, 3 and 6 months)
  • Time to healing of the principal ulcer(From the patient's off-loading device delivery visit to the date of healing validated by the adjudication committee)
  • Appearance of new ulcers on the affected foot and/or contralateral(6 months)
  • Requirement for amputation(6 months)
  • Incidence of infectious complications(6 months)
  • Observance of the equipment(6 months)
  • Patients satisfaction with the prescribed device(At 3 months)

研究者

发起方
Proteor Group
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of a New Device "Orthèse Diabète" in the... | 临床试验